Management of punding in Parkinson’s disease: an open-label prospective study

被引:0
|
作者
A. Fasano
L. Ricciardi
M. Pettorruso
A. R. Bentivoglio
机构
[1] Università Cattolica del Sacro Cuore Largo Agostino Gemelli,Istituto di Neurologia
[2] 8,Department of Neurosciences, Psychiatry and Anaesthesiological Science
[3] Neuromed Institute,Department of Psychiatry
[4] University of Messina,undefined
[5] Catholic University of Sacred Heart,undefined
来源
Journal of Neurology | 2011年 / 258卷
关键词
Amantadine; Parkinson’s disease; Punding; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.
引用
收藏
页码:656 / 660
页数:4
相关论文
共 50 条
  • [41] An open-label extension study to determine the safety of pirnavanserin in patients with Parkinson's disease and psychosis
    Mills, R.
    Johnson, A.
    Bahr, D.
    Williams, H.
    Revell, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S221 - S221
  • [42] Efficacy and safety of α-dihydroergocryptine in the treatment of early and advanced Parkinson's disease:: An open-label study
    Peng, R
    Zhou, D
    Lai, XH
    Yuan, GG
    MOVEMENT DISORDERS, 2004, 19 : S228 - S228
  • [43] Tolcapone in elderly patients with Parkinson's disease: A prospective open-label multicenter non-interventional trial
    Ebersbach, Georg
    Storch, Alexander
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 49 (01) : E40 - E44
  • [44] Punding prevalence in Parkinson's disease
    Miyasaki, Janis M.
    Al Hassan, Khalid
    Lang, Anthony E.
    Voon, Valerie
    MOVEMENT DISORDERS, 2007, 22 (08) : 1179 - 1181
  • [45] Punding in Parkinson's Disease: An Update
    Rajalingam, Rajasumi
    Fasano, Alfonso
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (07): : 1035 - 1047
  • [46] Severe punding in Parkinson's disease
    El Otmani, H.
    Raji, L.
    El Moutaouakil, B.
    Rafai, M. A.
    Slassi, I.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 (02): : 190 - 193
  • [47] A 6-month open-label trial of tolcapone in Parkinson's disease
    Charles, PD
    Davis, TL
    SaintHilaire, MH
    Trosch, RM
    LeWitt, P
    Kurth, MC
    Pedder, S
    Dorflinger, E
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M64 - M64
  • [48] Punding prevalence in Parkinson's disease
    Valenca, G.
    Glass, P.
    Negreiros, N.
    Duarte, M.
    Ventura, L.
    Mueller, M.
    Oliveira-Filho, J.
    MOVEMENT DISORDERS, 2011, 26 : S116 - S117
  • [49] Adoption (early levodopa with opicapone in Parkinson's patients with motor fluctuations) study in Parkinson's disease: Design and rationale of a randomized prospective, open-label exploratory trial
    Ferreira, Joaquim
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Costa, Raquel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 266 - 266
  • [50] The ADOPTION (eArly levoDopa with Opicapone in Parkinson's paTients wIth motOr fluctuatioNs) study in Parkinson's disease: design and rationale of a randomized prospective, open-label exploratory trial
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S171 - S172